Literature DB >> 22286388

Post-treatment follow-up procedures in cervical cancer patients previously treated with radiotherapy.

Seiji Mabuchi1, Fumiaki Isohashi, Shintaro Maruoka, Takeshi Hisamatsu, Tsuyoshi Takiuchi, Yasuo Yoshioka, Tadashi Kimura.   

Abstract

PURPOSE: We investigated the role of physical examination, CT scan, chest X-ray, and Pap smear in the routine follow-up program for cervical cancer patients previously treated with radiotherapy.
METHODS: The records of women who had developed recurrent cervical cancer after radiotherapy were retrospectively reviewed. The optimal procedure for the detection of recurrence was evaluated according to the disease-free interval (DFI). Survival analysis was performed based on the Kaplan-Meier method and comparisons between groups were made using the log-rank test.
RESULTS: A total of 146 recurrent cervical cancer patients were included in our database. The majority of recurrences were diagnosed either by symptoms, physical examination, or CT scan. The patients whose recurrent disease was detected by Pap smear, physical examination, or CT scan had a significantly longer survival than those detected by symptoms. When analyzed according to DFI, physical examination, and CT scan led to the detection of recurrence in patients with a DFI of 1-5 years. In contrast, chest X-ray and Pap smear only had a clinical impact on the diagnosis of recurrence in patients with a DFI of 1-2 years.
CONCLUSIONS: Chest X-ray and Pap smear can be routinely performed for the first 2 years after radiotherapy, but can be omitted or used sparingly thereafter.

Entities:  

Mesh:

Year:  2012        PMID: 22286388     DOI: 10.1007/s00404-012-2235-4

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

1.  The efficacy of surgical treatment of recurrent or persistent cervical cancer that develops in a previously irradiated field: a monoinstitutional experience.

Authors:  Seiji Mabuchi; Yuri Matsumoto; Naoko Komura; Masaaki Sawada; Mie Tanaka; Eriko Yokoi; Katsumi Kozasa; Akihiko Yoshimura; Hiromasa Kuroda; Tadashi Kimura
Journal:  Int J Clin Oncol       Date:  2017-05-27       Impact factor: 3.402

2.  Care-seeking behavior of Japanese gynecological cancer survivors suffering from adverse effects.

Authors:  Sumiko Oshima; Kengo Kisa; Takayoshi Terashita; Hidenobu Kawabata; Masaji Maezawa
Journal:  BMC Womens Health       Date:  2013-01-08       Impact factor: 2.809

3.  Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.

Authors:  Eriko Yokoi; Seiji Mabuchi; Ryoko Takahashi; Yuri Matsumoto; Hiromasa Kuroda; Katsumi Kozasa; Tadashi Kimura
Journal:  J Gynecol Oncol       Date:  2016-12-08       Impact factor: 4.401

4.  Significance of the Number and the Location of Metastatic Lymph Nodes in Locally Recurrent or Persistent Cervical Cancer Patients Treated with Salvage Hysterectomy plus Lymphadenectomy.

Authors:  Seiji Mabuchi; Naoko Komura; Michiko Kodama; Michihide Maeda; Yuri Matsumoto; Shoji Kamiura
Journal:  Curr Oncol       Date:  2022-07-11       Impact factor: 3.109

5.  Utility of risk-weighted surgical-pathological factors in early-stage cervical cancer.

Authors:  K Matsuo; S Mabuchi; M Okazawa; Y Matsumoto; T Tsutsui; M Fujita; S Kamiura; K Ogawa; C P Morrow; T Kimura
Journal:  Br J Cancer       Date:  2013-03-05       Impact factor: 7.640

6.  Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.

Authors:  Seiji Mabuchi; Fumiaki Isohashi; Mika Okazawa; Fuminori Kitada; Shintaro Maruoka; Kazuhiko Ogawa; Tadashi Kimura
Journal:  J Gynecol Oncol       Date:  2017-01       Impact factor: 4.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.